Tg Therapeutics (TGTX) Acquisitions (2011)
Tg Therapeutics (TGTX) recorded quarterly Acquisitions of $10386.0 in Q4 2011.
Tg Therapeutics (TGTX) Acquisitions (2011) Analysis & Trends
Tg Therapeutics' Acquisitions history runs 1 years deep, the most recent figure standing at $10386.0 for Q4 2011.
- In Q4 2011, Acquisitions changed N/A year-over-year to $10386.0; the TTM figure through Sep 2012 stood at $10386.0 (changed N/A YoY), while the FY2012 annual figure was $10386.0, changed N/A from the prior year.
- Acquisitions was $10386.0 for Q4 2011 at Tg Therapeutics.
- In the past five years, Acquisitions ranged from a high of $10386.0 in Q4 2011 to a low of $10386.0 in Q4 2011.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Tg Therapeutics | 7.71 Bn | 7.06 Bn | 171.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2011 | 10,386.00 |